Table 1 Clinicopathological features of 118 cases diagnosed with DCIS by preoperative biopsy
Parameters | Number of patients (n = 118) (%) |
|---|---|
Age at operation (years old) | 51 (30–78) |
Symptoms | |
 Asymptomatic / Symptomatic | 42 (35.6%) / 76 (64.4%) |
Palpability | |
 Impalpabe / Palpable | 33 (28.0%) / 85 (72.0%) |
Tumor size (mm) | 17.7 (3.0–50.0) |
Biopsy device | |
 Core needle biopsy / Vacuum-assisted biopsy | 67 (56.8%) / 51 (43.2%) |
Estrogen receptor | |
 Negative / Positive | 22 (18.6%) / 96 (81.4%) |
Progesterone receptor | |
 Negative / Positive | 37 (31.4%) / 81 (68.6%) |
HER2 | |
  ≤ 2 / 3 | 101 (85.6%) / 17 (14.4%) |
Ki67 | |
  ≤ 14% / > 14% | 98 (83.1%) / 20 (16.9%) |
Grade of DCIS | Â |
 Low, intermediate / High | 98 (83.1%) / 20 (16.9%) |
Comedonecrosis | |
 Absence / Presence | 54 (45.8%) / 64 (54.2%) |
Intraductal calcification | |
 Absence / Presence | 99 (83.9%) / 19 (16.1%) |
Lymphoid infiltrate | |
 Negative, mild / moderate, severe | 83 (70.3%) / 35 (29.7%) |
Postoperative pathology | |
 DCIS only / Invasive ductal carcinoma | 70 (59.3%) / 48 (40.7%) |
Platelets–lymphocyte ratio | median 138.9 (range, 55.0–292.0) |
 Low / High | 70 (59.3%) / 48 (40.7%) |
LDH | median 170 (range, 121–452) |
  ≤ ULN / >ULN | 105 (89.0%) / 13 (11.0%) |
CEA | median 1.6 (range, < 0.5–12.4) |
  ≤ ULN / >ULN | 111 (94.1%) / 7 (5.9%) |
CA15–3 | median 6.6 (range, < 0.5–40.8) |
  ≤ ULN / >ULN | 115 (97.5%) / 3 (2.5%) |